Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Sell
45,266
-60
-0.1% -$12.9K 1.9% 12
2026
Q1
$9.86M Sell
45,326
-5,040
-10% -$1.12M 1.81% 14
2025
Q4
$11.5M Sell
50,366
-301
-0.6% -$68.6K 2.16% 11
2025
Q3
$11.7M Sell
50,667
-1,163
-2% -$237K 2.23% 11
2025
Q2
$9.62M Sell
51,830
-68
-0.1% -$12.6K 1.92% 12
2025
Q1
$10.9M Sell
51,898
-1,517
-3% -$295K 2.31% 9
2024
Q4
$9.49M Buy
53,415
+318
+0.6% +$58.5K 1.97% 14
2024
Q3
$10.5M Buy
53,097
+1,809
+4% +$338K 2.16% 10
2024
Q2
$8.8M Buy
51,288
+518
+1% +$85.8K 1.94% 13
2024
Q1
$9.25M Sell
50,770
-1,187
-2% -$205K 2.05% 10
2023
Q4
$8.05M Sell
51,957
-6,658
-11% -$971K 1.93% 11
2023
Q3
$8.74M Buy
58,615
+828
+1% +$122K 2.27% 10
2023
Q2
$7.79M Sell
57,787
-1,429
-2% -$210K 1.95% 12
2023
Q1
$9.44M Sell
59,216
-4,566
-7% -$698K 2.37% 8
2022
Q4
$10.3M Buy
63,782
+2,089
+3% +$320K 2.59% 8
2022
Q3
$8.28M Sell
61,693
-2,194
-3% -$315K 2.35% 9
2022
Q2
$9.79M Sell
63,887
-1,321
-2% -$202K 2.6% 7
2022
Q1
$10.6M Sell
65,208
-2,828
-4% -$411K 2.45% 7
2021
Q4
$9.21M Buy
68,036
+3,389
+5% +$400K 2.17% 11
2021
Q3
$6.97M Sell
64,647
-4,584
-7% -$524K 1.95% 13
2021
Q2
$7.8M Sell
69,231
-200
-0.3% -$22.5K 2.19% 9
2021
Q1
$7.51M Sell
69,431
-1,776
-2% -$190K 2.26% 9
2020
Q4
$7.63M Buy
71,207
+1,013
+1% +$97.3K 2.53% 7
2020
Q3
$6.15M Buy
70,194
+5,758
+9% +$542K 2.38% 8
2020
Q2
$6.33M Sell
64,436
-1,053
-2% -$92.7K 2.75% 5
2020
Q1
$4.99M Buy
65,489
+1,139
+2% +$97K 2.35% 12
2019
Q4
$5.7M Buy
64,350
+1,339
+2% +$111K 2.03% 15
2019
Q3
$4.77M Buy
63,011
+3,161
+5% +$217K 1.81% 20
2019
Q2
$4.35M Buy
59,850
+39
+0.1% +$3.06K 1.94% 20
2019
Q1
$4.82M Buy
59,811
+868
+1% +$71K 2.21% 15
2018
Q4
$5.43M Buy
58,943
+278
+0.5% +$24.4K 2.74% 8
2018
Q3
$5.55M Sell
58,665
-311
-0.5% -$29.5K 2.47% 12
2018
Q2
$5.46M Sell
58,976
-532
-0.9% -$52K 2.61% 9
2018
Q1
$5.63M Sell
59,508
-6,038
-9% -$663K 2.74% 7
2017
Q4
$6.34M Sell
65,546
-1,859
-3% -$175K 2.86% 7
2017
Q3
$5.99M Sell
67,405
-2,668
-4% -$203K 2.82% 6
2017
Q2
$5.08M Sell
70,073
-1,815
-3% -$122K 2.43% 10
2017
Q1
$4.68M Buy
71,888
+2,496
+4% +$157K 2.29% 18
2016
Q4
$4.34M Sell
69,392
-157
-0.2% -$9.58K 2.23% 20
2016
Q3
$4.39M Buy
69,549
+1,285
+2% +$83.2K 2.35% 19
2016
Q2
$4.23M Sell
68,264
-1,105
-2% -$67.3K 2.29% 17
2016
Q1
$3.96M Buy
69,369
+150
+0.2% +$8.36K 2.24% 20
2015
Q4
$4.1M Buy
69,219
+1,843
+3% +$106K 2.43% 12
2015
Q3
$3.67M Buy
67,376
+240
+0.4% +$15.6K 2.51% 16
2015
Q2
$4.51M Buy
67,136
+595
+0.9% +$38.8K 2.84% 5
2015
Q1
$3.9M Buy
66,541
+1,080
+2% +$65.2K 2.48% 14
2014
Q4
$4.28M Buy
65,461
+8
+0% +$504 2.7% 8
2014
Q3
$3.78M Buy
65,453
+3,430
+6% +$190K 2.53% 12
2014
Q2
$3.5M Buy
62,023
+448
+0.7% +$23.5K 2.36% 13
2014
Q1
$3.17M Buy
61,575
+2,153
+4% +$109K 2.26% 18
2013
Q4
$3.14M Buy
59,422
+2,216
+4% +$109K 2.3% 16
2013
Q3
$2.56M Buy
57,206
+1,480
+3% +$65.6K 2.01% 24
2013
Q2
$2.3M Buy
+55,726
New +$2.44M 1.9% 24

Other funds holding ABBV

Iowa State Bank's ABBV Position: Q2 2026 in Review

Iowa State Bank reduced its AbbVie (ABBV) stake by 0.13% in Q2 2026, selling an estimated $12.9K and leaving 45,266 shares worth $11.4M. The position accounts for 1.9% of the portfolio, ranked #12.

Iowa State Bank first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.7M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Iowa State Bank held 45,266 shares of AbbVie worth $11.4M as of Q2 2026.
  • Iowa State Bank sold 60 AbbVie shares in Q2 2026, an estimated $12.9K.
  • AbbVie made up 1.9% of Iowa State Bank's portfolio in Q2 2026, its #12 holding.
  • Iowa State Bank first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Iowa State Bank's AbbVie position peaked at $11.7M in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Iowa State Bank's 13F filing for Q2 2026, filed 28 Jul 2026.